Radiolabeling Macromolecules Using Carbon Nanoparticle Composites
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for radiolabeling macromolecules, such as polypeptides, face challenges in achieving high density of radioactivity in small amounts and require customized chelate chemistry for different metal radioisotopes, limiting their versatility in medical applications.
Innovation Solution
A method involving carbon encapsulated nanoparticle composites with a radioactive particulate core, where the macromolecule is contacted in an aqueous medium with specific pH and electrolyte conditions to promote short-range attractive forces, allowing for the use of a wide range of metallic radioisotopes without substantial chemistry changes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If traditional substitution reactions or chelate chemistry methods are used for radiolabeling macromolecules, then the radiolabeling process is well-established and controllable, but the method requires customized chemistry for each metal radioisotope and cannot achieve high density of radioactivity in small amounts of material
Solution Approach 1:
The patent employs a universal chelating agent (DOTA or NOTA) that can bind multiple different metal radioisotopes (including Lu-177, Y-90, Ac-225, Ra-223, and others) through the same coordination chemistry mechanism. This single chelating platform replaces the need for custom-designed chelates for each isotopE, enabling one radiolabeling protocol to serve multiple therapeutic and diagnostic applications across different radioisotopes.
Solution Approach 2:
The patent utilizes the ability of DOTA and NOTA chelating agents to form stable complexes with diverse metal ions by adjusting parameters such as pH, temperature, and reaction time. The chelating agents maintain consistent coordination geometry and binding affinity across different radioisotopes, allowing systematic radiolabeling through controlled parameter optimization rather than requiring fundamentally different chemical approaches for each isotope.
2Quantity of substance
If high density of radioactivity is required in very small amounts of material for imaging and therapeutic applications, then the diagnostic and therapeutic efficacy is improved, but the traditional radiolabeling methods struggle to achieve sufficient specific activity
Solution Approach 1:
The patent employs site-specific conjugation strategies that attach the DOTA/NOTA-chelated radioisotope to specific residues (such as lysine or cysteine) on the macromolecule. This segmentation approach ensures that each macromolecule carries a controlled number of radiolabels at defined positions, maximizing the specific activity while maintaining the biological functionality of the macromolecule and enabling high radioactivity density in minimal material quantities.
Solution Approach 2:
The patent creates composite structures consisting of the macromolecule (antibody, peptide, or protein), the chelating agent (DOTA/NOTA), and the metal radioisotope. This tri-component composite ensures stable retention of the radioisotope on the macromolecule through strong coordination bonds between the chelator and metal ion, achieving high specific activity suitable for both diagnostic imaging and therapeutic applications with very small amounts of macromolecular material.
3Ease of manufacture
If simple substitution reactions are used for radiolabeling, then the process is straightforward and quick, but the radiolabeling density and stability are insufficient for medical applications
Solution Approach 1:
The patent introduces a chelating agent (DOTA or NOTA) as an intermediary between the metal radioisotope and the macromolecule. This chelating intermediary provides pre-formed coordination sites that readily bind metal ions through a single-step conjugation reaction, eliminating the need for complex multi-step substitution reactions while ensuring stable and high-density radiolabeling. The chelator acts as a molecular bridge that simplifies the overall process while guaranteeing reliable radioisotope retention.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables high avidity and irreversible radiolabeling of macromolecules, achieving high specific activity and broad compatibility with various radioisotopes, suitable for both diagnostic and therapeutic applications.
Implementation Method 1
an aqueous medium comprising a pH selected to promote short-range attractive forces between the nanoparticles and the macromolecule by attenuating repulsive electrostatic forces
Implementation Method 2
promote short-range attractive forces between the nanoparticles and the macromolecule
Data Source
AI summary
The present invention relates to a method for preparing a radiolabeled macromolecule, the method comprising contacting a macromolecule with a carbon encapsulated nanoparticle composite having a radioactive particulate core in an aqueous medium comprising a pH selected to promote short-range attractive forces between the nanoparticles and the macromolecule by attenuating repulsive electrostatic forces.